Dramatic improvement of segmental Zoster Paresis by late-onset antiviral therapy

Authors

Keywords:

Herpes zoster, Improvement, Paresis, Antiviral therapy

Abstract

Focal paresis secondary to Herpes zoster (HZ) is a rare neurological complication and should be kept in mind in the differential diagnosis of acute weakness with corresponding dermatomal rashes. In this case report, we illustrate an 84-year-old male patient, who presented with focal upper extremity weakness following HZ on right C4-8 dermatome. After clinical and electrophysiological evaluations, segmental zoster paresis was diagnosed. Although antiviral medication(oral brivudine) had been administered previously, oral valacyclovir and low dosage methylprednisolone were initiated. In the following 2 months interval, a progressive and dramatic recovery in extremity weakness and neuropathic pain were achieved. The clinical course of this patient may give substantial perspectives regarding the clinical evaluation of similar cases.

Abstract
0
pdf
0

Downloads

Published

2021-11-30

How to Cite

Dramatic improvement of segmental Zoster Paresis by late-onset antiviral therapy. (2021). Nepal Journal of Neuroscience, 18(4), 44-48. https://doi.org/10.3126/njn.v18i4.36631

Issue

Section

Case Report

How to Cite

Dramatic improvement of segmental Zoster Paresis by late-onset antiviral therapy. (2021). Nepal Journal of Neuroscience, 18(4), 44-48. https://doi.org/10.3126/njn.v18i4.36631